BRADENTON NEUROLOGY
3930 8th Avenue West
Bradenton, FL 34205
Telephone:
941-746-3115
FAX:
941-746-3201
BRADENTON RESEARCH CENTER
3924 9th Ave West
Bradenton, FL 34205
Telephone:
941-708-0005
FAX:
941-748-1156
EDUCATION
Emory University:
Atlanta, GA
Dates attended: 1967-70
Major: PHYSICS
Honor
Societies: Sigma Pi Sigma (National Physics Honor Society)
Alpha Epsilon Upsilon
Medical College of Georgia: Augusta, GA
Dates
Attended: 1970-74
Degree Obtained: M.D.
POSTGRADUATE TRAINING
Tucson Hospitals Medical Education Program: Tucson AZ
Internship in Internal Medicine: July, 1974-June, 1975
Resident in Internal Medicine: July, 1975-June, 1976
University of Arizona Department of Neurology
Neurology Resident: July, 1976-June, 1978
Chief Resident, Neurology: July, 1978-June, 1979
Multiple Sclerosis
Comprehensive Treatment Training Program
University of Texas Southwestern Medical School
June, 2002
PRACTICE POSITION
Private Practice in Neurology: Bradenton, FL 1979-Present
ACADEMIC POSITION
Assistant
Clinical Professor of Neurology
University of South Florida, Tampa, FL, 1981-1985
HOSPITAL STAFF APPOINTMENTS
Manatee Memorial Hospital: Active Staff
Medical
Executive Committee 1981-83
Lakewood Ranch Medical Center
Chairman, Neurosciences
Committee, Blake Medical Center, 2004-2009
Medical Director, Stroke Program, Blake Medical Center, 2004-2009
PROFESSIONAL ORGANIZATIONS
PROFESS Investigators Advisory Panel 2005
Epilepsy Foundation
of Southwest Florida: Professional Advisory Board
Director,
Manatee County Epilepsy Foundation Clinic: 1979-Present
American Academy of Neurology: Fellow
American Academy of Neurology: Critical Care and Emergency Neurology Section
American Academy of Neurology: Stroke and Vascular Neurology Section
American Academy of Neurology: Multiple Sclerosis Section
American Stroke
Association
Florida Medical Association
Manatee County Medical Society
American Medical Association
American Society
of Neuroimaging
American Academy of Physicians and Investigators
BOARD CERTIFICATION
Diplomate of the
American Board of Psychiatry and Neurology, a Member of American Board of Medical Specialties
Specialty of Neurology, April, 1981
Subspecialty
of Vascular Neurology, May, 2005
Certified, American Board of Independent Medical Examiners, 1996, 2001,
2006
Certification in MRI/CT, American Society of Neuroimaging: January 29, 2000
CLINICAL
TRIALS
DEMENTIA
PARKE DAVIS: Cognex Access Program, 1992-93
BAYER: Metrifonate for Alzheimer’s, 1997-98
SAEGIS: SGS-742, ALZHEIMERS: 2004
TAKEDA:
Rozerem in Alzheimer’s sleep disturbance 2006
MARTEK:
DHA in mild cognitive impairment. 2005-7
NOVARTIS:cena713d2340.
Exelon patch for Alzheimer’s Disease. 2007
EPILEPSY
WALLACE:
Felbatol LIFE Program, 1994
PARKE DAVIS: Neurontin
Dosage Titration Study, 1994
ORTHO-MCNEIL: Topamax
Drug Initiation Trial, 1997
UCB PHARMA: K.E.E.P.E.R
Study on Keppra for Seizures, 2000
GLAXO: TARGET Study
on Lamictal, 2000
GLAXO SMITHKLINE: LAM40117 (Lamictal)
study: 2002
SCHWARZ PHARMA: SPM 927 as adjunctive
therapy for epilepsy: SP 754 and 756 studies, 2004
ORTHO-MCNEIL:
Topirimate CAPSS-272: 2004
GLAXO SMITHKLINE:
LAM 40124 assessment for behavioral changes with lamotrigine and leveracitam.
EISAI: E2007-A001-206 study for refractory partial onset seizures
KING PHARMACEUTICALS: Vanquix epipen for acute repetitive seizures. 2007.
HEADACHE
SANDOZ: DHE 4,5 Nasal
Spray Study, 1995
GLAXO: Imitrex Postmarketing Surveillance
Study, 1994
MERCK: U.S. Migraine Assessment Program
(Maxalt), 1999
MULTIPLE SCLEROSIS
ACT: Cleveland Clinic-Biogen 2004
OPEXA: Tamoxofen MS Trial 2006
TEVA:
interferon antibodies. PM028 2006
ALLERGAN: Overactive
bladder in MS 2007
BIOMS: mbp8298 for secondary progressive
MS. 2007
MEDICINE
GLAXOSMITHKLINE: GSK716155. Treatment
of Diabetes type 2. 2007.
NEUROPATHY
MEM
MD 19: Forest Labs 2004
SCHWARZ PHARMA: SPM927
for Diabetic Neuropathy: SP 768 study, 2004-05
ORTHO
MCNEIL: Tramadol Neuropathy Trial, 2004
ALLERGAN:
Painful Diabetic Neuropathy. 203818. 2007
SANGAMO: SB-509
for Diabetic Neuropathy. 2007
PAIN/NEURALGIA
PfFIZER: Pregablin in the Treatment of Back Pain, 1999
PFIZER: Pregablin in the Treatment of Post-Herpetic Neuralgia, 2000
NEUROGESIX: NGX4010, PHN: 2003, 2005
DEPOMED: gabapentin in postherpetic neuralgia, 2005
NEUROGESIX: NGX-4010 for postherpetic neuralgia, 2005
PFIZER: PHN trial, 2006
DURECT:
Clin005-0009 Bupivicaine for PHN. 2007.
KING PHARMACEUTICALS:
K862-06-2001 T-62 for PHN. 2007.
PARKINSONS
SANDOZ: Parlodel in the treatment of
Parkinson’s Disease, 1979, University of Arizona
BOEHRINGER-INGELHEIM:
NS2330, Parkinsons: 2003-2004
NOVARTIS:
Stalevo End of Dose Study: 2005
MERK: PADDY
1 trial for Parkinson’s treatment associated dyskinesia, 2005
OVATION: Hallucinations with Parkinson’s Disease Treatment, 2005
BOEHRINGER INGELHEIM:
Pramipaxol in Early Parkinsons. 2005-6
SCHWARZ PHARMACEUTICALS:
SP921. Rotigotine Transdermal System in advanced
Parkinson’s. 2007.
VASCULAR
LOREX: Eliprodil for Treatment
of Cerebral Infarct, 1996-97
BOEHRINGER-INGELHEIM:
PROFESS: 2003-07
NEUROBIOLOGICAL
TECHNOLOGIES: ANCROD Acute Stroke Trial: 2006-07
ROCKET:
Duke University, Rivaroxaman for CVA prevention in Atrial Fibrillation, 2007
LICENSURE
Florida: ME 0033896
Arizona: 15779
South Carolina: 13324
North Carolina: 112232
AWARDS
AMA Physician Recognition Award: 1982, 1985, 1988, 1991, 1994, 1997, 2000, 2004
AMA Physician Recognition Award with Commendation: 2007
Epilepsy
Foundation of Southwest Florida Outstanding Patient Service Award, 1994
Fellow, American Academy of Neurology,
1998
Strathmore’s Who’s Who, 1999
Guide To Top Doctors, 1999, 2006: Center for the Study of Services
Marquis “Who’s
Who in Medicine and Healthcare”, 2000-2001
Gold Quill Award, Manatee Memorial Hospital, November 21, 2000
Marquis
“Who’s Who in Finance and Industry”, 2002-2003
PUBLICATIONS
McElveen WA. “Post-Herpetic
Neuralgia”: eMedicine Journal: Neurology [serial online]. April, 2001, volume 2, number 4. Available at http://www.emedicine.com
McElveen, WA. “Cerebral
Venous Thrombosis”: eMedicine Journal: Neurology [serial online]. January 2001, volume 2, number 1. Available at http://www.emedicine.com
Dworkin RH et
al. “Pregabalin for the Treatment of Postherpetic Neuralgia” Neurology:
2003;60:1274-1283 (Investigator)
McElveen,
WA and Alway, D. (2009) “Ischemic
Stroke and Transient Ischemic Attack: Evaluation and Management” Stroke Essentials for Primary Care
Ed Alway, D and Cole, JW. Humana Press. pp 9-34.
McElveen, WA (2009) “Cerebral
Venous Thrombosis” Stroke Essentials for Primary Care Ed: Alway, D and Cole, JW. Humana Press.
pp 183-194
McElveen, WA
and Macko, R.(2009) “Pathophysiology and Management of Acute Stroke” Stroke Recovery
and Rehabilitation. ed: Stein, J et al. demosMEDICAL. pp
45-59
McElveen, WA(2009)
“Management of Sinovenous Thrombosis” Stroke:
A Practical Approach Ed: Geyer, JD. and Gomez, CR. Lippincott
Williams & Wilkins. pp 308-311
CME PRESENTATIONS
MRI Fellowship Program, CME certification
by American Society of Neuroimaging. June 29, 2002, Orlando, FL
MRI Fellowship Program, CME certification by American Society of Neuroimaging, “MRI in Multiple Sclerosis” February 8-9, 2003,
Sarasota, FL
Stroke Certification Program, CME
certification by Blake Medical Center, “Tools of the Trade…Neurological Assessment” March 9, 2005, Bradenton,
FL
Optimizing Stroke Service Line Management, WRG Research, Inc “The Physician as Champion for Stroke Unit” June 21, 2007, Arlington, VA
